HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy | MicrobiomeTrials← Back to trialsNCT04798014
HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy
CompletedOBSERVATIONAL
Trial Details
Start: 2021-05-26Est. Completion: 2023-08-15
Enrollment target: 860 participants Locations- Indiana University School of Medicine, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
Bronchiectasis Adult
Study design: observational, retrospective Population: 270 patients diagnosed with bronchiectasis (BX) treated at the Re…
A Coruña, SpainEst. completion Oct 1, 2026
Cystic FibrosisLung Transplant; Complications
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Cleveland, United StatesCompleted Feb 1, 2026
SUSPENDED
Non-cystic Fibrosis Bronchiectasis
This is a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score at 24 weeks of…
Phoenix, United StatesCompleted Oct 29, 2027